We are live on ! Find out more
ARRY

Array Biopharma Inc
ARRY

Delisted

ARRY was delisted on the 29th of July, 2019.

Back to rankings

143 hedge funds and large institutions have $571M invested in Array Biopharma Inc in 2013 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 42 increasing their positions, 50 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

59% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 17

50% more funds holding in top 10

Funds holding in top 10: 4 → 6 (+2)

7% more funds holding

Funds holding: 134 → 143 (+9)

12% less capital invested

Capital invested by funds: $651M → $571M (-$79.8M)

16% less repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 50

83% less call options, than puts

Call options by funds: $771K | Put options by funds: $4.48M

Holders
143
Holders Change
+9
Holders Change %
+6.72%
% of All Funds
4.15%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.17%
New
27
Increased
42
Reduced
50
Closed
17
Calls
$771K
Puts
$4.48M
Net Calls
-$3.71M
Net Calls Change
-$2.71M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$43.5M
2
TCM
TimesSquare Capital Management
New York
+$13.7M
3
RG
Redmile Group
California
+$4.31M
4
DM
Deerfield Management
New York
+$3.54M
5
PA
Pinnacle Associates
New York
+$3.37M

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$11.8M
2
GC
GMT Capital
Georgia
-$9.85M
3
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$8.39M
4
PI
Putnam Investments
Massachusetts
-$3.73M
5
PA
Perceptive Advisors
New York
-$3.56M
Name Holding Trade Value Shares
Change 		Change in
Stake
ST
126
Stifel Trust
Missouri
$39K +$6.94K +1,275 +20%
TRCT
127
Tower Research Capital (TRC)
New York
$38K -$39.9K -7,330 -49%
PNC Financial Services Group
128
PNC Financial Services Group
Pennsylvania
$32K – – –
FMT
129
First Mercantile Trust
Tennessee
$28K -$10.7K -1,965 -26%
WIL
130
Winifred I. Li
$21K +$5.99K +1,100 +36%
Teacher Retirement System of Texas
131
Teacher Retirement System of Texas
Texas
$20K -$58.7K -10,787 -73%
Envestnet Asset Management
132
Envestnet Asset Management
Illinois
$8K -$180 -33 -2%
BNP Paribas Financial Markets
133
BNP Paribas Financial Markets
France
$7.59K -$165K -30,308 -95%
Creative Planning
134
Creative Planning
Kansas
$4K – – –
DADC
135
D.A. Davidson & Co
Montana
$4K +$5.33K +979 New
Dimensional Fund Advisors
136
Dimensional Fund Advisors
Texas
$2K – – –
MAS
137
Madden Advisory Services
Florida
$2K +$1.63K +300 New
ARMC
138
American Research & Management Company
Massachusetts
$1K +$544 +100 New
Fifth Third Bancorp
139
Fifth Third Bancorp
Ohio
$1K +$637 +117 New
EWM
140
Elite Wealth Management
Washington
$1K +$719 +132 New
TAM
141
Tocqueville Asset Management
New York
$1K +$1.36K +250 New
Manulife (Manufacturers Life Insurance)
142
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$451 +$20.4K +3,740 +4%
DIA
143
Denver Investment Advisors
Colorado
$88 +$10.3K +1,897 +12%
Lord, Abbett & Co
144
Lord, Abbett & Co
New Jersey
– -$8.39M -1,349,084 Closed
PA
145
Perceptive Advisors
New York
– -$3.56M -572,870 Closed
State of Wisconsin Investment Board
146
State of Wisconsin Investment Board
Wisconsin
– -$2.8M -450,000 Closed
FC
147
FBR & Co
Virginia
– -$706K -113,500 Closed
First Manhattan
148
First Manhattan
New York
– -$404K -65,000 Closed
GCP
149
GSA Capital Partners
United Kingdom
– -$215K -34,486 Closed
RFC
150
Russell Frank Company
Washington
– -$167K -26,839 Closed
3 4 5
6
7

ARRY Hedge Fund Activity: Q4 2013 in Review

143 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Array Biopharma Inc (ARRY) for Q4 2013, worth a combined $571M — down 12% from $651M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new ARRY positions and 17 closed out — a net gain of 10 holders — while 42 added to existing stakes and 50 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $43.5M. The largest seller was BVF Inc, cutting an estimated $11.8M.

  • 143 institutional investors held Array Biopharma Inc (ARRY) as of Q4 2013, up from 134 in Q3 2013.
  • Funds reported $571M of Array Biopharma Inc stock for Q4 2013, down 12% quarter-over-quarter.
  • 27 funds opened new Array Biopharma Inc positions in Q4 2013 and 17 closed out, a net change of +10 holders.
  • The largest Array Biopharma Inc buyer in Q4 2013 was Fidelity Investments, an estimated $43.5M added.
  • The largest Array Biopharma Inc seller in Q4 2013 was BVF Inc, an estimated $11.8M sold.

Based on aggregated 13F filings for Q4 2013.